INFINITT Healthcare Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on INFINITT Healthcare Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how INFINITT Healthcare Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with INFINITT Healthcare Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Business Description
INFINITT Healthcare Co Ltd (Infinite Healthcare) is engaged in the development and provision of medical image information solutions, primarily focusing on PACS and 3D medical imaging software. The company serves the medical IT industry, providing optimized software solutions for clinical departments, data migration, and equipment integration. Infinite Healthcare's products and services are utilized by approximately 6,300 medical institutions across 55 countries.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company is engaged in research and development activities focused on creating optimized medical imaging and information solutions applicable across various medical departments, including Radiology, Cardiology, Orthopedics, Dentistry, Radiotherapy, and Ophthalmology. The company is committed to developing advanced PACS through its research and development efforts. The company adheres to industry standards and is involved in government and national projects. It carries out R&D activities through its office in Seoul, Korea. In FY2024, the company spent KRW9,208.3 million on its R&D activities, which as a percentage of revenue stood at 9% and grew 6.6% YoY.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer